SCHEMBL17188

SCHEMBL17188

CC(=O)NC[C@H]1CN(S(=O)(=O)C2=CC=CCC2=S)CCN1c1ccc([C@](C)(O)C(F)(F)F)cc1

nearest known ligand 0.46

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GCK P35557 14/20 0.46
GCKR Q14397 7/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17729 0.92 GCK (0.47) GCKGCKR
SCHEMBL17103 0.90 GCK (0.46) GCKGCKR
SCHEMBL17400 0.90 GCK (0.46) GCKGCKR
SCHEMBL17076 0.90 GCK (0.47) GCKGCKR
SCHEMBL12077797 0.89 GCKR (0.49) GCKGCKR
SCHEMBL17013 0.89 GCKR (0.48) GCKGCKR
SCHEMBL16646 0.89 GCKR (0.48) GCKGCKR
SCHEMBL16158 0.89 GCKR (0.48) GCKGCKR
SCHEMBL17365 0.89 GCK (0.46) GCKGCKR
SCHEMBL17534 0.89 GCK (0.49) GCKGCKR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2609081-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES Amgen Inc. (US) 2013-07-03 EP disclosed
WO-2012027261-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES AMGEN INC. (US) 2012-03-01 WO disclosed